These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1425597)

  • 1. Proteolysis is a key process in virus replication.
    Kemp G; Webster A; Russell WC
    Essays Biochem; 1992; 27():1-16. PubMed ID: 1425597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral proteinases--possible targets of antiviral drugs.
    Maliar T; Baláz S; Tandlich R; Sturdík E
    Acta Virol; 2002; 46(3):131-40. PubMed ID: 12580374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral proteases: an emerging therapeutic target.
    Korant BD
    Crit Rev Biotechnol; 1988; 8(2):149-57. PubMed ID: 3067861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of proteolysis in the reproduction of animal and human viruses and the antiviral activity of protease inhibitors].
    Lozitskiĭ VP; Poliak RIa
    Usp Sovrem Biol; 1982; 93(3):352-62. PubMed ID: 6810571
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
    Nijhuis M; van Maarseveen NM; Boucher CA
    Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral therapy: prospects for protease inhibitors.
    Korant BD; Towatari T; Ivanoff L; Petteway S; Brzin J; Lenarcic B; Turk V
    J Cell Biochem; 1986; 32(2):91-5. PubMed ID: 3023407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus NS3-4A protease inhibitors: countering viral subversion in vitro and showing promise in the clinic.
    Thomson JA; Perni RB
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):606-17. PubMed ID: 17002221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targets for inhibition of hepatitis C virus replication.
    Littlejohn M; Locarnini S; Bartholomeusz A
    Antivir Ther; 1998; 3(Suppl 3):83-91. PubMed ID: 10726058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiviral activity of proteinase inhibitors in cultured cells infected with alpha-viruses].
    Zhirnov OP; Ovcharenko AV; Mel'nikova EE; Gaĭdamovich SIa; Bukrinskaia AG
    Mol Gen Mikrobiol Virusol; 1985 Dec; (12):30-6. PubMed ID: 3025688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of hetarylhydrazones.
    Tonew M; Tonew E; Indulen MK; Dzeguze DR; Oehring H; Schmidt J
    Acta Virol; 1982 May; 26(3):130-6. PubMed ID: 6127013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
    Stoermer MJ; Chappell KJ; Liebscher S; Jensen CM; Gan CH; Gupta PK; Xu WJ; Young PR; Fairlie DP
    J Med Chem; 2008 Sep; 51(18):5714-21. PubMed ID: 18729351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
    Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
    J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-protein interactions as targets for antiviral chemotherapy.
    Loregian A; Marsden HS; Palù G
    Rev Med Virol; 2002; 12(4):239-62. PubMed ID: 12125015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting viral proteases: challenges and opportunities.
    Bianchi E; Pessi A
    Biopolymers; 2002; 66(2):101-14. PubMed ID: 12325160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents.
    Supuran CT; Casini A; Scozzafava A
    Med Res Rev; 2003 Sep; 23(5):535-58. PubMed ID: 12789686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibitors of hepatitis C virus replication.
    Neyts J
    Antiviral Res; 2006 Sep; 71(2-3):363-71. PubMed ID: 16843538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral drug discovery targeting to viral proteases.
    Hsu JT; Wang HC; Chen GW; Shih SR
    Curr Pharm Des; 2006; 12(11):1301-14. PubMed ID: 16611117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-interferon cellular products capable of virus inhibition.
    Kumar S; Baron S
    Tex Rep Biol Med; 1981-1982; 41():395-401. PubMed ID: 7348875
    [No Abstract]   [Full Text] [Related]  

  • 20. Perspectives on antiviral drug development.
    Wainberg MA
    Antiviral Res; 2009 Jan; 81(1):1-5. PubMed ID: 18948140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.